Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can paroxetine improve well-being in patients with irritable bowel syndrome who do not respond to a high-fiber diet?

Nature Clinical Practice Gastroenterology & Hepatology volume 1, pages 14–15 (2004)Cite this article

boxed-textTabas G et al. (2004) Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial. Am J Gastroenterology 99: 914–920

SSRIs seem to provide a substantial improvement in overall well-being in patients with IBS without significantly altering specific bowel symptoms

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Creed F et al. (2003) The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124: 303–317

    Article  Google Scholar 

  2. Jailwala J et al. (2000) Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 133: 136–147

    Article  CAS  Google Scholar 

  3. Gruber AJ et al. (1996) The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine: fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psych Clin N Am 19: 351–369

    Article  CAS  Google Scholar 

  4. Onghena P et al. (1992) Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 49: 205–219

    Article  CAS  Google Scholar 

  5. Whitehead WE et al. (1999) Definition of a responder in clinical trials for functional gastrointestinal disorders: report on a symposium. Gut 45 (Suppl 2): II78–II79

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Ruth Kirby, Research Highlights Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Gastroenterology, Wolfson Digestive Diseases Centre, University Hospital, Nottingham, UK

    Robin Spiller

Authors
  1. Robin Spiller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robin Spiller.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spiller, R. Can paroxetine improve well-being in patients with irritable bowel syndrome who do not respond to a high-fiber diet?. Nat Rev Gastroenterol Hepatol 1, 14–15 (2004). https://doi.org/10.1038/ncpgasthep0002

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0002

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing